N-[[4-(2-aminoacetyl)phenyl]methyl]-N-(1,3-dimethyl-2-oxobenzimidazol-5-yl)methanesulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(1,3-dimethyl-2-oxobenzimidazol-5-yl)methanesulfonamide
C39H41F2N9O8S2 — CID 158912011
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[4-(2-aminoacetyl)phenyl]methyl]-N-(1,3-dimethyl-2-oxobenzimidazol-5-yl)methanesulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(1,3-dimethyl-2-oxobenzimidazol-5-yl)methanesulfonamide
N-[[4-(2-aminoacetyl)phenyl]methyl]-N-(1,3-dimethyl-2-oxobenzimidazol-5-yl)methanesulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(1,3-dimethyl-2-oxobenzimidazol-5-yl)methanesulfonamide (PubChem CID 158912011) has the molecular formula C39H41F2N9O8S2 and a molecular weight of 865.94 g/mol. Its IUPAC name is N-[[4-(2-aminoacetyl)phenyl]methyl]-N-(1,3-dimethyl-2-oxobenzimidazol-5-yl)methanesulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(1,3-dimethyl-2-oxobenzimidazol-5-yl)methanesulfonamide.
Molecular Properties
| Compound Name | N-[[4-(2-aminoacetyl)phenyl]methyl]-N-(1,3-dimethyl-2-oxobenzimidazol-5-yl)methanesulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(1,3-dimethyl-2-oxobenzimidazol-5-yl)methanesulfonamide |
|---|---|
| PubChem CID | 158912011 |
| Molecular Formula | C39H41F2N9O8S2 |
| Molecular Weight | 865.94 g/mol |
| Exact Mass | 865.25 |
| IUPAC Name | N-[[4-(2-aminoacetyl)phenyl]methyl]-N-(1,3-dimethyl-2-oxobenzimidazol-5-yl)methanesulfonamide;N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]-N-(1,3-dimethyl-2-oxobenzimidazol-5-yl)methanesulfonamide |
| SMILES | Cn1c(=O)n(C)c2cc(N(Cc3ccc(-c4nnc(C(F)F)o4)cc3)S(C)(=O)=O)ccc21.Cn1c(=O)n(C)c2cc(N(Cc3ccc(C(=O)CN)cc3)S(C)(=O)=O)ccc21 |
| InChI | InChI=1S/C20H19F2N5O4S.C19H22N4O4S/c1-25-15-9-8-14(10-16(15)26(2)20(25)28)27(32(3,29)30)11-12-4-6-13(7-5-12)18-23-24-19(31-18)17(21)22;1-21-16-9-8-15(10-17(16)22(2)19(21)25)23(28(3,26)27)12-13-4-6-14(7-5-13)18(24)11-20/h4-10,17H,11H2,1-3H3;4-10H,11-12,20H2,1-3H3 |
| InChIKey | JGTOAGACDYXNHP-UHFFFAOYSA-N |
| XLogP | 3.82 |
| TPSA | 210.63 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 60 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 865.94 |
| LogP ≤ 5 | 3.82 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 15 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158912011 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.